Johnson & Johnson (JNJ)

130.31
NYSE : Health Technology
Prev Close 132.07
Day Low/High 130.19 / 132.39
52 Wk Low/High 121.00 / 148.99
Avg Volume 6.88M
Exchange NYSE
Shares Outstanding 2.66B
Market Cap 350.65B
EPS 5.70
P/E Ratio 24.46
Div & Yield 3.80 (2.77%)
Cramer: The Stock Market Is Helping the Consumer This Year

Cramer: The Stock Market Is Helping the Consumer This Year

It could well be the stock market, not the Fed, that is driving our retail and services.

J&J: Don't Overpay for Lukewarm Results

J&J: Don't Overpay for Lukewarm Results

Its long-term reputation appears to be supporting the shares far more than they deserve.

Cramer: 3 Stocks Say Interest Rates Are Going Higher

Cramer: 3 Stocks Say Interest Rates Are Going Higher

Be aware that Johnson & Johnson, American Electric Power and Federal Realty don't roll over idly.

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet and NuVasive Could be a Spine-Tingling Combination

Zimmer Biomet is on track to return to growth, which could signal more mergers and acquisitions within the industry.

Don't Disrespect This Bull Market

Don't Disrespect This Bull Market

There are plenty of doubters about the market and its record highs.

Valeant Scores 'Vindicating Win' as 2 Key Drugs Clear FDA Hurdles

Valeant Scores 'Vindicating Win' as 2 Key Drugs Clear FDA Hurdles

Valeant could rake in more than $1 billion annually in new sales after FDA approval of a key drug.

Closing Bell: S&P Cuts Outlook on Deutsche; Dow Seals New Record

Closing Bell: S&P Cuts Outlook on Deutsche; Dow Seals New Record

Better-than-expected earnings from Johnson & Johnson pushed the Dow Jones Industrial Average to close out the day with another record.

Cramer: In Earnings Tests, JNJ Gets an A While Netflix Flunks

Cramer: In Earnings Tests, JNJ Gets an A While Netflix Flunks

It depends on the type of test and who's doing the grading.

Midday Report: Monsanto Rebuffs Bayer Again; S&P 500 Declines

Midday Report: Monsanto Rebuffs Bayer Again; S&P 500 Declines

A rush of earnings kept investors busy throughout the morning. Netflix was one of the biggest drags on the Nasdaq and S&P 500.

Johnson & Johnson Has an Impressive Growth Story, Says Jim Cramer

Johnson & Johnson Has an Impressive Growth Story, Says Jim Cramer

Johnson & Johnson's earnings reveal just how impressive growth is at the big pharma company, according to Jim Cramer.

Johnson & Johnson Tops Earnings Estimates

Johnson & Johnson Tops Earnings Estimates

The health care giant's quarterly earnings and sales clocked in well above analyst expectations.

Morning Movers: NFLX, JNJ, VMW, GES

Morning Movers: NFLX, JNJ, VMW, GES

Netflix underwhelmed analysts as subscriber growth came up short.

What to Watch Tuesday: Goldman Sachs Earnings, June Housing Starts

What to Watch Tuesday: Goldman Sachs Earnings, June Housing Starts

On Tuesday, July 19, investors will focus on the U.S. banking sector when Goldman Sachs reports second quarter results.

Cramer: These Stocks Are the Key to the Bull Market

Cramer: These Stocks Are the Key to the Bull Market

Let me give you the unassailable themes.

What to Watch This Week: Bank of America, Goldman Sachs, Netflix and Yahoo! Report Earnings

What to Watch This Week: Bank of America, Goldman Sachs, Netflix and Yahoo! Report Earnings

For the week of July 18, the earnings parade continues, with dozens of major companies reporting financial results.

Cramer: For Ackman, It's Like Free-Agency Time in the NFL

Cramer: For Ackman, It's Like Free-Agency Time in the NFL

He needs Mondelez to make a deal -- any deal.

J&J, Realty Income and Lockheed Will Keep Flying

J&J, Realty Income and Lockheed Will Keep Flying

Defense stocks, like Lockheed Martin, will likely continue to be in favor says Huntington Bank's Chief Investment Officer John Augustine.

Cramer: 10 Stocks That Need to Start Doing Better

Cramer: 10 Stocks That Need to Start Doing Better

They need to do something that makes them stand out as stocks you want to own, not avoid.

Johnson & Johnson Headed Higher & Higher

Charts point to a $174 price target for the cosumer-goods giant.

Jim Cramer: Second Quarter Was Controlled by Oil

Jim Cramer: Second Quarter Was Controlled by Oil

The second quarter comes to a close today and the real theme of the past three months is that oil controlled the direction of the stock market.

Beware the Pitfalls of Stock Market Headlines

Anyone who buys Tesla based on Elon Musk's fantastical view deserves their fate. 

Cramer: The 3 Stocks That Will Tell You If the Rally Is Real

One bank, one oil firm and one tech stock that you need to watch. 

Cramer: There's a Lot Out There That's Tempting

But the situation in Europe is nowhere near running its course.

Cramer: Here's the Game Plan for Dealing With the Fed, Brexit and Oil

Be cautious for now, but be ready to put some of that mad money to work in higher-yielding, all-domestic equities.

Lancôme's China Bubble Bursts Amid Free Speech Pop Star Drama

The cancellation of a Cantopop star's concert has mired the cosmetics brand in scandal.

Cramer: The Money Will Flow to the Best International Stories

Let's go over what allows us to get to highs for the year.

Jim Cramer Is Watching Janet Yellen's Speech Early Next Week

Jim Cramer Is Watching Janet Yellen's Speech Early Next Week

Federal Reserve Chair Janet Yellen should say the Fed can't raise interest rates right now when she speaks in Philadelphia on Monday, according to Jim Cramer.

Cramer: Many Portfolio Managers Hope for the 'Wrong' Jobs Number

This is because they would buy more of the winning stocks lower.

Cramer: These Voices Say Not to Give Up on This Market

Do the homework and you'll find great stocks.